NCT01650597 - A Single Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-42165279 in Healthy Male Participants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions

Healthy VolunteersPharmacokinetics

Interventions

DRUG

JNJ-42165279 2.5 - 500 mg oral

Type=exact number, unit=mg, numbers=2.5, 10, 30, 100, 250 and 500, form=suspension, route=oral use. One single dose administered orally.

DRUG

Placebo

Type=exact number, unit=mg, form=solution, route=oral use. One single dose administered orally.

DRUG

JNJ-42165279 100 mg oral

Type=exact number, unit=mg, form=solution, route=oral use. One single dose administered orally.

Trial Locations (1)

Merksem